ALADDIN RX's Sunscreen Selected for 'Cosmo Trends 2026' at Cosmoprof North America Miami

Got story updates? Submit your updates here. ›

ADP-Derma Inc., a specialist in clinical dermatological solutions, announced that its skincare brand, ALADDIN RX, has been selected for the prestigious 'Cosmo Trends 2026' report at Cosmoprof North America Miami. The company's 'DA500 Barrier Protection Sun Cream' was spotlighted in the 'Gentle Power' category, a trend emphasizing high-efficacy, low-irritation solutions designed for sensitive skin. Following this recognition, ADP-Derma is set to accelerate its expansion into the North American market with the establishment of a U.S. subsidiary and the development of new FDA-compliant OTC sunscreen lines.

Why it matters

This selection validates ALADDIN RX's commitment to authentic skin science, as the brand has integrated proven recovery mechanisms from its professional 'Aladdin Peeling' treatment, which has recorded over 1 million clinical procedures. The recognition also highlights the brand's unique heritage in medical aesthetics and its focus on delivering results proven in clinical fields rather than relying on marketing hype.

The details

The DA500 Sun Cream targets the 'Golden Hour,' the critical recovery window immediately following professional skin treatments when the skin barrier is most vulnerable. The product's 'DA500' technology utilizes active ingredients with a molecular weight over 500 Daltons, which minimizes dermal absorption to significantly reduce irritation while providing robust protection on the skin's surface. BEAUTYSTREAMS, the global trend authority, praised this innovative formulation in the 'Cosmo Trends 2026' report.

• ALADDIN RX's 'DA500 Barrier Protection Sun Cream' was selected for the 'Cosmo Trends 2026' report at Cosmoprof North America Miami in February 2026.
• ADP-Derma is set to establish a U.S. subsidiary in early 2026 to accelerate its expansion into the North American market.

What they’re saying

What’s next

Following this recognition, ADP-Derma is set to accelerate its expansion into the North American market with the establishment of a U.S. subsidiary in early 2026. The company plans to secure local distribution channels and introduce new product lines, including the development of Over-the-Counter (OTC) sunscreens tailored to U.S. FDA standards and local consumer preferences.